Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion type Assertion NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_head.
- NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion description "[Patients with colon tumours and who were homozygous GSTT1(*)2 genotype carriers were more likely than patients who expressed GSTT1 to have their DNA alkylated (83 versus 32%, P=0.03) and to have higher O(6)-MedG levels (0.178+/-0.374 versus 0.016+/-0.023 micromol O(6)-MedG/mol dG, P=0.04) in normal, but not tumour, DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_provenance.
- NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion evidence source_evidence_literature NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_provenance.
- NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion SIO_000772 11448648 NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_provenance.
- NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion wasDerivedFrom befree-20140225 NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_provenance.
- NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_assertion wasGeneratedBy ECO_0000203 NP900774.RACI79aeNx8yhsa9UMUQU1ErLSbjGg_V4ahj19vaYYXTw130_provenance.